OA10051A - Peptides that block human immunodeficiency virus i - Google Patents

Peptides that block human immunodeficiency virus i Download PDF

Info

Publication number
OA10051A
OA10051A OA60343A OA60343A OA10051A OA 10051 A OA10051 A OA 10051A OA 60343 A OA60343 A OA 60343A OA 60343 A OA60343 A OA 60343A OA 10051 A OA10051 A OA 10051A
Authority
OA
OAPI
Prior art keywords
gly
glycine
group
pro
peptide
Prior art date
Application number
OA60343A
Other languages
English (en)
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Peter Horal
Stig Jeansson
Original Assignee
Syntello Vaccine Dev Kb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello Vaccine Dev Kb filed Critical Syntello Vaccine Dev Kb
Publication of OA10051A publication Critical patent/OA10051A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA60343A 1990-08-22 1993-02-17 Peptides that block human immunodeficiency virus i OA10051A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57108090A 1990-08-22 1990-08-22

Publications (1)

Publication Number Publication Date
OA10051A true OA10051A (en) 1996-10-14

Family

ID=24282265

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60343A OA10051A (en) 1990-08-22 1993-02-17 Peptides that block human immunodeficiency virus i

Country Status (17)

Country Link
EP (1) EP0545991B1 (de)
JP (1) JP3115596B2 (de)
KR (1) KR100220531B1 (de)
AT (1) ATE173934T1 (de)
AU (1) AU667290B2 (de)
BR (1) BR9106772A (de)
CA (1) CA2088788C (de)
DE (1) DE69130571T2 (de)
DK (1) DK0545991T3 (de)
ES (1) ES2128322T3 (de)
FI (1) FI930519L (de)
GR (1) GR3029523T3 (de)
HU (1) HUT63177A (de)
MC (1) MC2306A1 (de)
NO (1) NO930401L (de)
OA (1) OA10051A (de)
WO (1) WO1992003147A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101370509A (zh) * 2006-01-13 2009-02-18 安克瑞格公司 化合物连同γ辐射在用于治疗癌症中的应用
FR2925501B1 (fr) * 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925500B1 (fr) * 2007-12-21 2011-05-06 Vincience Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803117A (en) 1972-03-24 1974-04-09 Abbott Lab Tetrapeptide
US3781272A (en) 1972-03-24 1973-12-25 Abbott Lab Tripeptide
EP0245362B1 (de) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
JPH06504035A (ja) 1994-05-12
GR3029523T3 (en) 1999-06-30
ES2128322T3 (es) 1999-05-16
DE69130571T2 (de) 1999-06-17
AU8433291A (en) 1992-03-17
WO1992003147A1 (en) 1992-03-05
AU667290B2 (en) 1996-03-21
MC2306A1 (fr) 1993-09-27
NO930401L (no) 1993-02-17
BR9106772A (pt) 1993-07-20
NO930401D0 (no) 1993-02-05
DE69130571D1 (de) 1999-01-14
DK0545991T3 (da) 1999-08-16
KR100220531B1 (ko) 1999-10-01
JP3115596B2 (ja) 2000-12-11
FI930519A7 (fi) 1993-04-21
FI930519L (fi) 1993-04-21
CA2088788C (en) 2003-12-16
HU9300456D0 (en) 1993-05-28
HUT63177A (en) 1993-07-28
FI930519A0 (fi) 1993-02-05
EP0545991B1 (de) 1998-12-02
EP0545991A1 (de) 1993-06-16
ATE173934T1 (de) 1998-12-15
CA2088788A1 (en) 1992-02-23

Similar Documents

Publication Publication Date Title
US5447915A (en) Terminally blocked antiviral peptides
US5756449A (en) Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease
Chanh et al. Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response
Cianciolo et al. Human retrovirus-related synthetic peptides inhibit T lymphocyte proliferation
US5627035A (en) Peptides that block human immunodeficiency virus and methods of use thereof
EP0579363A1 (de) Behandlung von tropikalischer spastischer Paresis mit Peptide T
US6011014A (en) Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
US5346989A (en) Peptides for use in induction of T cell activation against HIV-1
AU5656890A (en) Chemically modified cd4 peptide fragments having anti-retroviral properties
EP0545991B1 (de) Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen
JP2004538334A (ja) Ｈｉｖ感染の治療に使用される薬剤とその成分と使用法
EP0960886B1 (de) T-peptid und damit verwandte Peptide in der Behandlung von entzündungen einschlies slich der Multiplen Sklerose
RU2126266C1 (ru) Способ ингибирования ретровирусной инфекции (варианты), ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора
WO1992021377A1 (en) Peptides for use in induction of t cell activation against hiv-1
US7285621B2 (en) Multiple branch peptide construction
Kieber-Emmons et al. Immunological characteristics of the putative CD4-binding site of the HIV-1 envelope protein
US6964763B1 (en) Methods and compositions for inhibiting HIV infectivity and blocking chemokine activity
Kikukawa-Itamura et al. Quantitative analysis of cytotoxicity induced by HTLV-I carrying cells against a human lymphoblastoid cell line, Molt-4
JP3725899B2 (ja) Ｈｉｖに対して使用するための多分岐ペプチド構築物
JP3725899B6 (ja) Ｈｉｖに対して使用するための多分岐ペプチド構築物
Bausback et al. Functionally important domains of C9 as defined by monoclonal antibodies to C9 inhibiting hemolysis
US20030060599A1 (en) Tripeptide amides that block viral infectivity and methods of use thereof
Sarin et al. Lymphadenopathy-Associated Virus) by
NAIR et al. Immunopathogenesis of HIV